INA
Basic information
Region (hg38): 10:103277138-103290346
Previous symbols: [ "NEF5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 25 | 1 | 0 |
Variants in INA
This is a list of pathogenic ClinVar variants found in the INA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-103277216-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
10-103277219-T-G | not specified | Uncertain significance (Oct 25, 2024) | ||
10-103277269-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
10-103277321-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
10-103277351-A-G | not specified | Uncertain significance (Nov 21, 2023) | ||
10-103277357-C-T | not specified | Uncertain significance (Nov 03, 2022) | ||
10-103277368-G-T | not specified | Uncertain significance (Jun 18, 2024) | ||
10-103277404-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
10-103277420-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
10-103277461-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
10-103277465-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
10-103277526-C-A | not specified | Uncertain significance (Jan 23, 2023) | ||
10-103277603-A-G | not specified | Uncertain significance (Dec 14, 2022) | ||
10-103277683-A-G | not specified | Uncertain significance (Mar 28, 2023) | ||
10-103277693-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
10-103277720-G-A | not specified | Uncertain significance (Nov 24, 2024) | ||
10-103277733-G-C | not specified | Uncertain significance (Oct 12, 2022) | ||
10-103277770-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
10-103277773-G-A | Abnormal brain morphology | Likely pathogenic (-) | ||
10-103277788-G-C | not specified | Uncertain significance (Jan 03, 2024) | ||
10-103277818-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
10-103277834-T-C | not specified | Uncertain significance (Mar 07, 2023) | ||
10-103277919-C-A | Likely benign (Mar 02, 2018) | |||
10-103277977-G-T | not specified | Uncertain significance (Aug 01, 2022) | ||
10-103278010-G-A | High myopia | Uncertain significance (Dec 17, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INA | protein_coding | protein_coding | ENST00000369849 | 3 | 13189 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.48e-8 | 0.219 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.13 | 166 | 263 | 0.631 | 0.0000125 | 3132 |
Missense in Polyphen | 61 | 106.03 | 0.57533 | 1248 | ||
Synonymous | 1.41 | 100 | 120 | 0.836 | 0.00000587 | 1070 |
Loss of Function | 0.419 | 13 | 14.7 | 0.882 | 6.29e-7 | 189 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000183 | 0.000182 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000272 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Class-IV neuronal intermediate filament that is able to self-assemble. It is involved in the morphogenesis of neurons. It may form an independent structural network without the involvement of other neurofilaments or it may cooperate with NF-L to form the filamentous backbone to which NF-M and NF-H attach to form the cross-bridges.;
Recessive Scores
- pRec
- 0.263
Intolerance Scores
- loftool
- 0.191
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.49
Haploinsufficiency Scores
- pHI
- 0.301
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.853
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ina
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype;
Zebrafish Information Network
- Gene name
- inab
- Affected structure
- VaP motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- branchiness
Gene ontology
- Biological process
- substantia nigra development;cell differentiation;neurofilament cytoskeleton organization;postsynaptic actin cytoskeleton organization;postsynaptic intermediate filament cytoskeleton organization;cellular response to leukemia inhibitory factor
- Cellular component
- extracellular space;nucleoplasm;neurofilament;nuclear membrane;cytoplasmic ribonucleoprotein granule;myelin sheath;intermediate filament cytoskeleton;Schaffer collateral - CA1 synapse;postsynapse
- Molecular function
- structural constituent of cytoskeleton;structural constituent of postsynaptic actin cytoskeleton;structural constituent of postsynaptic intermediate filament cytoskeleton